BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 698051)

  • 1. Lymphocyte response to antigen stimulation as measured by fluorescence polarization (SCM test).
    Pritchard JA; Sutherland WH
    Br J Cancer; 1978 Aug; 38(2):339-43. PubMed ID: 698051
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of human lymphocytes to PHA and tumour-associated antigens as detected by fluorescence polarization.
    Balding P; Light PA; Preece AW
    Br J Cancer; 1980 Jan; 41(1):73-85. PubMed ID: 6153900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of polarizing luminescence in the study of changes in the cytoplasm of lymphocytes--SCM test].
    Benes J
    Sb Lek; 1984 Sep; 86(8-9):245-50. PubMed ID: 6209784
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of lymphocyte stimulation by flow cytometry: differences in cells from patients with and without neoplasia.
    Hartmann W; Sackmann E; Eisert WG; Eisert R; Fliedner TM
    Biomedicine; 1980 Dec; 32(4):185-8. PubMed ID: 7470580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour specificity of the SCM test for cancer diagnosis.
    Chaitchik S; Asher O; Deutsch M; Weinreb A
    Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1165-70. PubMed ID: 2416568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the SCM-test for the diagnosis of cancer.
    Deutsch M; Weinreb A
    Eur J Cancer Clin Oncol; 1983 Feb; 19(2):187-93. PubMed ID: 6681765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of T lymphocytes to phytohaemagglutinin (PHA) and to cancer-tissue-associated antigens, measured by the intracellular fluorescence polarization technique (SCM test).
    Orjasaeter H; Jordfald G; Svendsen I
    Br J Cancer; 1979 Oct; 40(4):628-33. PubMed ID: 387060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of fluorescence polarization of human blood lymphocytes (SCM test) in the diagnosis of cancer.
    Schnuda ND
    Cancer; 1980 Sep; 46(5):1164-73. PubMed ID: 7214300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of melanoma by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes.
    Merimsky O; Kaplan B; Deutsch M; Tirosh R; Weinreb A; Chaitchik S
    Cancer Detect Prev; 1997; 21(2):167-77. PubMed ID: 9101078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on fluorescence polarization of human blood lymphocytes (SCM test) using a Percoll gradient centrifugal separation method].
    Tenzaki T; Matsumoto J; Ishiguro T; Yoshida Y; Sugiyama S
    Rinsho Byori; 1984 Apr; 32(4):394-8. PubMed ID: 6088848
    [No Abstract]   [Full Text] [Related]  

  • 11. Adaptation of the cellscan technique for the SCM test in breast cancer.
    Rahmani H; Deutsch M; Ron I; Gerbat S; Tirosh R; Weinreb A; Chaitchik S; Lalchuk S
    Eur J Cancer; 1996 Sep; 32A(10):1758-65. PubMed ID: 8983287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte fluorescence polarization changes after phytohemagglutinin stimulation in the diagnosis of colorectal carcinoma.
    Hocking GR; Rolland JM; Nairn RC; Pihl E; Cuthbertson AM; Hughes ES; Johnson WR
    J Natl Cancer Inst; 1982 Apr; 68(4):579-83. PubMed ID: 6951073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical assessment of fluorescence polarisation changes in lymphocytes stimulated by phytohaemagglutinin (PHA) in malignant and benign diseases.
    Pritchard JA; Sutherland WH; Siddall JE; Bater AJ; Kerby IJ; Deeley TJ; Griffith G; Sinclair R; Davies BH; Rimmer A; Webster DJ
    Eur J Cancer Clin Oncol; 1982 Jul; 18(7):651-9. PubMed ID: 6751831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte fluorescence polarization measurements with the cellscan system: application to the SCM cancer test.
    Deutsch M; Ron I; Weinreb A; Tirosh R; Chaitchik S
    Cytometry; 1996 Feb; 23(2):159-65. PubMed ID: 8742175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Response of human lymphocytes to phytohemagglutinin (PHA) as measured by fluorescence polarization technique--differences between malignant conditions and benign or healthy conditions].
    Tenzaki T; Ishiguro T
    Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):817-25. PubMed ID: 2778375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of cytoplasmic viscosity by fluorescence polarization in phytohemagglutinin-stimulated and unstimulated human peripheral lymphocytes.
    Hashimoto Y; Shinozaki N
    J Histochem Cytochem; 1988 Jun; 36(6):609-13. PubMed ID: 3367046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cellular fluidity of peripheral blood lymphocytes from patients with urogenital cancers by a fluorescence polarization technique: PHA response and prognosis.
    Sakamoto S; Maeda H; Yamasaki K; Aikawa S; Hinuma Y
    Eur J Cancer Clin Oncol; 1981 Oct; 17(10):1105-15. PubMed ID: 7200019
    [No Abstract]   [Full Text] [Related]  

  • 18. Biophysical differentiation between lymphocytes from healthy donors, patients with malignant diseases and other disorders.
    Cercek L; Cercek B; Franklin CI
    Br J Cancer; 1974 May; 29(5):345-52. PubMed ID: 4136566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytofluorimetry of fluorescein fluorescence polarization to assay lymphocyte activation.
    Dimitropoulos K; Rolland JM; Nairn RC
    Biochem Biophys Res Commun; 1986 May; 136(3):1021-9. PubMed ID: 2424436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in structuredness of cytoplasmic matrix in single stimulated lymphocytes from healthy donors and patients with non-malignant and malignant diseases.
    Hashimoto Y; Takaku F; Yamanaka T
    Br J Cancer; 1979 Jul; 40(1):156-60. PubMed ID: 454560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.